EPB41L4A and cancer: EPB41L4A-AS1 is abnormally expressed in a variety of cancers: it is downregulated in non-small cell lung cancer8 and bone marrow-derived mesenchymal stem cells9, and is upregulated in colorectal cancer10, osteosarcoma11, and neuroblastoma12.